<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-18">July 18, 2016.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Frank</forename><surname>Bloos</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Evelyn</forename><surname>Trips</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, EIDEC</roleName><forename type="first">Axel</forename><surname>Nierhaus</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Josef</forename><surname>Briegel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Daren</forename><forename type="middle">K</forename><surname>Heyland</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ulrich</forename><surname>Jaschinski</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Onnen</forename><surname>Moerer</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andreas</forename><surname>Weyland</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Gernot</forename><surname>Marx</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Matthias</forename><surname>Gründling</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>Kluge</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ines</forename><surname>Kaufmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Klaus</forename><surname>Ott</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Quintel</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Florian</forename><surname>Jelschen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Patrick</forename><surname>Meybohm</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sibylle</forename><surname>Rademacher</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andreas</forename><surname>Meier-Hellmann</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>Utzolino</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Udo</forename><forename type="middle">X</forename><surname>Kaisers</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Putensen</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Gunnar</forename><surname>Elke</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Maximilian</forename><surname>Ragaller</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Herwig</forename><surname>Gerlach</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD, MBA</roleName><forename type="first">Katrin</forename><surname>Ludewig</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Kiehntopf</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Holger</forename><surname>Bogatsch</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christoph</forename><surname>Engel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD;</roleName><forename type="first">Frank</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Markus</forename><surname>Loeffler</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Konrad</forename><surname>Reinhart</surname></persName>
							<email>konrad.reinhart@med.uni-jena.de</email>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tobias</forename><surname>Schürholz</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Karin</forename><surname>Dey</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Armin</forename><surname>Sommerer</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Claudia</forename><surname>Spies</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Friedhelm</forename><surname>Bach</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">T</forename><surname>Grote</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>John</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jens</forename><surname>Nentwich</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thomas</forename><surname>Schrauzer</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Kai</forename><surname>Zacharowski</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sven-Olaf</forename><surname>Kuhn</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Niels</forename><surname>Riedemann</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Yasser</forename><surname>Sakr</surname></persName>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Immo Gummelt</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Medicine 4</orgName>
								<orgName type="department" key="dep2">Intensive Care</orgName>
								<orgName type="institution">University Hospital Erlangen-Nürnberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ole</forename><surname>Bayer</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Johannes</forename><surname>Winning</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Fritz</forename><surname>Fiedler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Norbert</forename><surname>Weiler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Dirk</forename><surname>Schädler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Philipp</forename><surname>Simon</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ursula</forename><surname>Hoffmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Patrick</forename><surname>Möhnle</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Matthias</forename><surname>Angstwurm</surname></persName>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Markus</forename><surname>Löffler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Johannes</forename><surname>Bickenbach</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thorben</forename><surname>Beeker</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Florian</forename><surname>Feld</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tim-Philipp</forename><surname>Simon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hospital</forename><surname>Augsburg</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Maria</forename><surname>Zanquila</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Wolfgang</forename><surname>Von Scheidt</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Dea</forename><surname>Humar</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andreas</forename><surname>Blüthgen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Meike</forename><surname>Fahrenholz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Charité</forename><surname>Berlin</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Dirk</forename><surname>Eggert-Doktor</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Lojewski</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sibylle</forename><surname>Semmler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Marit</forename><surname>Habicher</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Susanne</forename><surname>Niederberger</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Martin</forename><surname>Krebs</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Birgit</forename><surname>Puhlmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stephanie</forename><surname>Scholz</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Juliane</forename><surname>Rau</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Martin</forename><surname>Schuster</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sabine</forename><surname>Savelsberg</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Vietzke</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hospital</forename><surname>Bielefeld</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ingobert</forename><surname>Wenningmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>Weber</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Nils</forename><surname>Theuerkauf</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ulf</forename><surname>Günther</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Kerstin</forename><surname>Sengebusch</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jana</forename><surname>Kötteritzsch</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Georgi</surname></persName>
						</author>
						<author>
							<persName><roleName>MD;</roleName><forename type="first">Birgit</forename><surname>Gottschlich</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sibylle</forename><surname>Feldmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Kai</forename><forename type="middle">Uwe</forename><surname>Döbel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sindy</forename><surname>Zachau</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Konrad</forename><surname>Mutschler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sabine</forename><surname>Recknagel-Friese</surname></persName>
						</author>
						<author>
							<persName><roleName>MD;</roleName><forename type="first">Christian</forename><surname>Icke</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tilmann</forename><surname>Von Spiegel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jochim</forename><surname>Schlordt</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ingrid</forename><surname>Weißbrod</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Simone</forename><surname>Lindau</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Felix</forename><surname>Jaeger</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tobias</forename><surname>Bingold</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Barbara</forename><surname>Pullmann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Carolin</forename><surname>Wiedenbeck</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Pense</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Anselm</forename><surname>Bräuer</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andrea</forename><surname>Kernchen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thorsten</forename><surname>Perl</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jörn</forename><surname>Schäper</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Frank</forename><surname>Mielck</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Cornelia</forename><forename type="middle">Iris</forename><surname>Koch</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thomas</forename><surname>Steinke</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Henning</forename><surname>Ebelt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Bubel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Daniel</forename><surname>Frings</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Geraldine</forename><surname>De Heer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Petzoldt</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Eike</forename><surname>Martin</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christoph</forename><surname>Seiler</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Johannes</forename><surname>Zimmermann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD;</roleName><forename type="first">Serin</forename><surname>Schiessling</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Martin</forename><surname>Brauer</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andreas</forename><surname>Kortgen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Helga</forename><surname>Skupin</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Carsten</forename><surname>Herzog</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Isabella</forename><surname>Westermann</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<addrLine>Erlanger Allee 101</addrLine>
									<postCode>07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Research JAMA Internal Medicine | Original Investigation</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="department" key="dep2">Center for Sepsis Control &amp; Care</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena, Germany (Bloos, Ludewig, Brunkhorst, Reinhart)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Centre Leipzig</orgName>
								<orgName type="department" key="dep2">Department of Intensive Care Medicine</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<addrLine>Loeffler)</addrLine>
									<settlement>Leipzig, Germany (Trips, Bogatsch</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">University Hospital Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">Nierhaus, Kluge</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="laboratory">Clinical Evaluation Research Unit</orgName>
								<orgName type="institution">University Hospital Munich</orgName>
								<address>
									<addrLine>Kaufmann)</addrLine>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Anesthesiology</orgName>
								<orgName type="department" key="dep2">Surgical Intensive Care Medicine</orgName>
								<orgName type="institution">Kingston General Hospital</orgName>
								<address>
									<addrLine>Ott)</addrLine>
									<settlement>Kingston, Hospital Augsburg, Augsburg, Germany (Jaschinski</settlement>
									<region>Ontario</region>
									<country>Canada (Heyland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution">University Hospital Göttingen</orgName>
								<address>
									<settlement>Göttingen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution" key="instit1">Quintel)</orgName>
								<orgName type="institution" key="instit2">University Hospital Oldenburg</orgName>
								<address>
									<settlement>Oldenburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Jelschen)</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Department of Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital Rheinisch-Westfälische Technische Hochschule Aachen</orgName>
								<address>
									<settlement>Aachen, Germany (Marx)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital Greifswald</orgName>
								<address>
									<country>Germany (Gründling</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Department of Anesthesiology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Intensive Care Medicine and Pain Therapy</orgName>
								<orgName type="institution">University Hospital Frankfurt</orgName>
								<address>
									<settlement>Frankfurt</settlement>
									<country>Germany (Meybohm</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Department of Nephrology and Intensive Care Medicine</orgName>
								<address>
									<settlement>Charité Berlin, Berlin</settlement>
									<country>Germany (Rademacher</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Department of Anesthesiology</orgName>
								<orgName type="department" key="dep2">Intensive Care Medicine and Pain Therapy</orgName>
								<orgName type="institution">HELIOS Hospital Erfurt</orgName>
								<address>
									<settlement>Erfurt</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Department of General Surgery</orgName>
								<orgName type="institution">Meier-Hellmann</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country>Germany (Utzolino</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department">Department of Anesthesiology and Surgical Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital Leipzig</orgName>
								<address>
									<settlement>Leipzig</settlement>
									<country>Germany (Kaisers</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country>Germany (Putensen</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="institution">University Medical Center Kiel</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="department" key="dep2">Department of Anesthesiology</orgName>
								<orgName type="department" key="dep3">Surgical Intensive Care Medicine and Pain Therapy</orgName>
								<orgName type="institution" key="instit1">Elke</orgName>
								<orgName type="institution" key="instit2">University Hospital Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country>Germany (Ragaller</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department">Institute for Clinical Chemistry</orgName>
								<orgName type="institution">Vivantes Hospital Neukölln</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country>Germany (Gerlach</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">Institute for Medical Informatics, Statistics and Epidemiology</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena</settlement>
									<country>Germany (Kiehntopf</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<settlement>Leipzig, Germany (Engel</settlement>
									<region>Loeffler)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="department">Department of Intensive Care</orgName>
								<orgName type="institution">University Hospital Rheinisch-Westfälische Technische Hochschule Aachen</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department">Department of Anesthesiology and Surgical Intensive Care</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">Department of Anesthesiology and Intensive</orgName>
								<orgName type="institution">Hospital of the Bundeswehr Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="department">Department of Nephrology and Intensive</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="department">Department of Anesthesiology, Intensive Care, Transfusion and Emergency Medicine and Pain Therapy: Friedhelm Bach</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">MD; University Hospital Dresden</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="department" key="dep1">Department of Anesthesiology</orgName>
								<orgName type="department" key="dep2">Intensive Care Medicine and Pain</orgName>
								<orgName type="institution">HELIOS Hospital</orgName>
								<address>
									<settlement>Erfurt</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Westküstenklinikum Heide</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="department">Department of Anesthesiology</orgName>
								<orgName type="institution" key="instit1">Elisabeth-Hospital Essen: Ingo Voigt</orgName>
								<orgName type="institution" key="instit2">University Hospital Frankfurt</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department">Intensive Care Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department" key="dep1">Department of General Surgery: Stefan Utzolino</orgName>
								<orgName type="department" key="dep2">Department</orgName>
								<orgName type="institution" key="instit1">MD</orgName>
								<orgName type="institution" key="instit2">University Hospital Freiburg</orgName>
								<orgName type="institution" key="instit3">University Hospital Göttingen</orgName>
								<address>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">MD; University Hospital Greifswald</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="department">Department of Anesthesiology and Surgical Intensive Care</orgName>
								<orgName type="institution">University Hospital Halle</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department">Department of Intensive Care</orgName>
								<orgName type="institution" key="instit1">MD</orgName>
								<orgName type="institution" key="instit2">University Hospital Hamburg-Eppendorf</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">MD; University Hospital Heidelberg</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="department">Association of Sodium Selenite and Procalcitonin-Guided Therapy With Mortality Original Investigation Research</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<orgName type="institution">Otto-von-Guericke-University Magdeburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock A Randomized Clinical Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-18">July 18, 2016.</date>
						</imprint>
					</monogr>
					<idno type="MD5">2AC07AF095BEEE2D92A44C3A2235B279</idno>
					<idno type="DOI">10.1001/jamainternmed.2016.2514</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Bloos</term>
					<term>Ludewig</term>
					<term>Brunkhorst</term>
					<term>Reinhart); Clinical Trial Dr Loeffler was responsible for the data analysis</term>
					<term>and Ms Trips conducted the data analysis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>for SepNet Critical Care Trials Group IMPORTANCE High-dose intravenous administration of sodium selenite has been proposed to improve outcome in sepsis by attenuating oxidative stress.</s><s>Procalcitonin-guided antimicrobial therapy may hasten the diagnosis of sepsis, but effect on outcome is unclear.</s></p><p><s>OBJECTIVE To determine whether high-dose intravenous sodium selenite treatment and procalcitonin-guided anti-infectious therapy in patients with severe sepsis affect mortality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DESIGN, SETTING, AND PARTICIPANTS</head><p><s>The Placebo-Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis (SISPCT), a multicenter, randomized, clinical, 2 × 2 factorial trial performed in 33 intensive care units in Germany, was conducted from November 6, 2009, to June 6, 2013, including a 90-day follow-up period.</s></p><p><s>INTERVENTIONS Patients were randomly assigned to receive an initial intravenous loading dose of sodium selenite, 1000 μg, followed by a continuous intravenous infusion of sodium selenite, 1000 μg, daily until discharge from the intensive care unit, but not longer than 21 days, or placebo.</s><s>Patients also were randomized to receive anti-infectious therapy guided by a procalcitonin algorithm or without procalcitonin guidance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAIN OUTCOMES AND MEASURES</head><p><s>The primary end point was 28-day mortality.</s><s>Secondary outcomes included 90-day all-cause mortality, intervention-free days, antimicrobial costs, antimicrobial-free days, and secondary infections.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Of 8174 eligible patients, 1089 patients (13.3%) with severe sepsis or septic shock were included in an intention-to-treat analysis comparing sodium selenite (543 patients [49.9%]) with placebo (546 [50.1%]) and procalcitonin guidance (552 [50.7%]) vs no procalcitonin guidance (537 [49.3%]).</s><s>The 28-day mortality rate was 28.3% (95% CI, 24.5%-32.3%) in the sodium selenite group and 25.5% (95% CI, 21.8%-29.4%)</s><s>(P = .30)</s><s>in the placebo group.</s><s>There was no significant difference in 28-day mortality between patients assigned to procalcitonin guidance (25.6% [95% CI, 22.0%-29.5%])</s><s>vs no procalcitonin guidance (28.2% [95% CI, 24.4%-32.2%])</s><s>(P = .34).</s><s>Procalcitonin guidance did not affect frequency of diagnostic or therapeutic procedures but did result in a 4.5% reduction of antimicrobial exposure.</s></p><p><s>CONCLUSIONS AND RELEVANCE Neither high-dose intravenous administration of sodium selenite nor anti-infectious therapy guided by a procalcitonin algorithm was associated with an improved outcome in patients with severe sepsis.</s><s>These findings do not support administration of high-dose sodium selenite in these patients; the application of a procalcitonin-guided algorithm needs further evaluation.</s></p><p><s>TRIAL REGISTRATION clinicaltrials.gov</s><s>Identifier: NCT00832039</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Patients</head><p><s>Adults with severe sepsis or septic shock (termed severe sepsis) beginning not later than 24 hours before randomization were eligible for this study; definitions were reported previously. <ref type="bibr" target="#b22">16</ref></s><s>riefly, severe sepsis was defined as systemic inflammatory response syndrome caused by infection combined with acute organ dysfunction.</s><s>Septic shock was defined as sepsis in combination with arterial hypotension or need for vasopressor therapy despite adequate fluid resuscitation.</s><s>Pregnant or lac-tating women, patients with selenium intoxication, individuals with infections for which guidelines recommend a longer duration of antimicrobial therapy, immunocompromised patients, and those without commitment for full therapy or where death was imminent owing to coexisting diseases were excluded from the trial (eMethods in Supplement 2).</s><s>As stated, written informed consent was obtained from all patients or their legal representatives.</s><s>If this was not possible before enrollment, the ethics committees approved a deferred consent process where the inability to provide consent was confirmed by an independent physician.</s><s>As soon as the legal representative of the patient was available, written informed consent was immediately obtained; otherwise, the patient was withdrawn from the study and all study procedures were ended.</s><s>No financial compensation was given.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Interventions</head><p><s>Using a 2 × 2 factorial design, we randomly assigned patients to receive intravenous sodium selenite or placebo as well as antimicrobial therapy guided by a procalcitonin algorithm or conventional antimicrobial therapy without procalcitonin guidance with an allocation ratio of 1:1:1:1 by use of a central randomization web server.</s><s>Randomization was stratified by study center, sex, and sepsis severity. <ref type="bibr" target="#b24">17</ref></s><s>Assignment to the placebo or sodium selenite group was concealed with identical vial labels by the drug provider.</s><s>Because of the nature of the procedure, the procalcitonin guidance group and related conventional therapy group were treated in an unblinded fashion.</s></p><p><s>Patients randomized to the sodium selenite group received an initial intravenous loading dose of 1000 μg (biosyn Corporation) followed by a continuous intravenous infusion of sodium selenite, 1000 μg/d, until discharge from the ICU, but not longer than 21 days.</s><s>The control group received placebo (sodium chloride, 0.9%; biosyn Corporation) intravenously following the same schedule.</s></p><p><s>In patients randomized to the procalcitonin guidance arm, procalcitonin was measured locally on days 0, 1, 4, 7, 10, and 14 after randomization if the patient was still in the ICU.</s><s>Procalcitonin concentration was assessed at each study site with time-resolved amplified cryptate-emission technology with a measurement range of 0.1 to 200 ng/mL, a functional assay sensitivity of at least 0.06 ng/mL, and a lower detection limit of at least 0.1 ng/mL.</s><s>Procalcitonin concentration on day 0 or day 1 served as the baseline value.</s><s>Depending on the procalcitonin results, an algorithm provided recommendations to change or discontinue antimicrobial therapy or trigger diagnostic procedures to optimize source control.</s><s>On day 4, no change in antimicrobial therapy was recommended if the procalcitonin level dropped by at least 50% compared with the baseline value.</s><s>Otherwise, change or optimization of antimicrobial therapy or interventions regarding source control were recommended.</s><s>On the other days, stopping antimicrobial therapy was recommended if the procalcitonin level was 1 ng/mL or lower or if the procalcitonin level dropped by at least 50% compared with the previous value.</s><s>Otherwise, change or optimization of antimicrobial therapy or interventions regarding source control were recommended (eTable 1 in Supplement 2).</s></p><p><s>Upon study initiation, personnel at each site were trained to request the decisions from the treating physicians at the times indicated in the study design.</s><s>The treating physician was allowed to overrule the algorithm recommendation.</s><s>In the group without procalcitonin guidance, no procalcitonin measurements were obtained until day 14; changes in antimicrobial therapy were made at the discretion of the treating physician.</s><s>Investigators agreed to treat all patients according to the Guidelines of the Germany Sepsis Society, <ref type="bibr" target="#b25">18</ref> which included recommendations to reevaluate antimicrobial therapy after 48 to 72 hours and to restrict duration of antimicrobial therapy to no more than 10 days.</s><s>Costs of antimicrobial therapy were calculated by multiplying the dosages of individual prescriptions by the price taken from a large purchaser community of German hospitals.</s><s>After the trial, selenium plasma concentrations were measured in retained samples by atomic absorption spectrometry (ZEEnit 60; Analytik Jena AG) at days 0, 1, 4, 10, and 14.</s><s>Procalcitonin plasma concentrations of all patients were measured on the same days.</s><s>All samples were stored at −80°C at the central study laboratory in Jena, Germany.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>The primary outcome of the study was death from any cause by 28 days after inclusion.</s><s>The study was planned to detect an absolute difference of 10% in the primary end point with a significance level of .05 and a power of 0.9 for both factors.</s><s>Assuming 40% mortality in the standard treatment arm (placebo with no procalcitonin guidance), 248 evaluable patients per arm were required.</s><s>Accounting for an expected dropout rate of 15%, we decided to include 295 patients per arm (1180 in total).</s><s>Secondary end points were 90-day all-cause mortality, mean total Sequential Organ Failure Assessment (SOFA) score and its subscores, duration of ICU and hospital stay, and ventilator-, vasopressor-, and dialysis-free days until day 90.</s><s>Additional secondary end points for the procalcitonin vs conventional group were duration and costs of antimicrobial therapy, duration until change of antimicrobial therapy, antimicrobial exposure days, days free of antimicrobial therapy, frequency of surgical source control, frequency of diagnostic procedures for localization of the infection focus, clinical and microbiologic treatment response, secondary infections, and emergence of antibiotic-resistant bacteria (definitions available in eTable 2 in Supplement 2).</s><s>A statistical analysis plan specified the tests for the end points and planned subgroup analyses (medical vs surgical patients, Acute Physiology and Chronic Health Evaluation [APACHE] II score &lt;25 points vs ≥25 points, severe sepsis vs septic shock, &lt;3 vs ≥3 organ dysfunctions at inclusion, and pneumonia vs abdominal infection).</s><s>Imputations were performed for missing variables of the SOFA, Simplified Acute Physiology Score, and APACHE II scores; other missing values were treated as such.</s><s>One interim analysis was conducted after recruitment of half of the planned sample size and presented to the data monitoring committee.</s></p><p><s>The significance level for the primary end point was adjusted by the α spending method <ref type="bibr" target="#b26">19,</ref><ref type="bibr" target="#b27">20</ref> resulting in a significance level of P = .006</s><s>in the interim analysis and P = .04</s><s>for the final analysis.</s><s>All other tests were conducted on the nominal level of P = .05</s><s>because these statistical comparisons were performed with exploratory intention.</s><s>The interaction was assessed by a logistic regression model for the 28-day mortality adjusting for age, sex, SOFA score at baseline, renal replacement at baseline, and treatment with sodium selenite before randomization.</s><s>If the interaction term was statistically significant, the analysis plan recommended comparison of only patients randomized either to the placebo and procalcitonin guidance arm or to the sodium selenite and no procalcitonin guidance arm with the standard arm.</s><s>To further investigate the nature of a possible interaction, longitudinal blood concentration profiles of selenium were compared to see whether they differed between the procalcitonin arms and whether procalcitonin plasma concentrations differed between the sodium selenite arms.</s><s>The statistical analysis was conducted consistent with the intention-to-treat principle.</s></p><p><s>The primary end point 28-day mortality was assessed by the χ 2 test for each factor.</s><s>Secondary end points were analyzed by the χ 2 test, exact χ 2 test, t test, Wilcoxon rank sum test, Kaplan-Meier product limit estimate, or log-rank test, as appropriate.</s><s>The cumulative number of days of antimicrobial exposure per cumulative number of ICU days were compared using a rate ratio test.</s><s>All reported P values are 2-sided.</s><s>Statistical analyses were performed with SAS, version 9.2 (SAS Institute Inc); SPSS, version 22.0 (SPSS Inc); and R, version 3.1.0</s><s>(R Foundation).</s><s>Data analysis was performed from February 10 to October 20, 2014.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Between November 6, 2009, and March 8, 2013, a total of 8174 patients were screened and 1180 patients were randomized; 91 patients were excluded from the final analysis because informed consent was not obtainable in the deferred consent process, resulting in 1089 patients with evaluable data (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Of these, 947 patients (87.0%) had septic shock.</s><s>Overall, the baseline characteristics of the 4 study groups were well balanced.</s><s>However, requirement for renal replacement ranged from 13.2% to 22.2%; age and the disease severity marker midregional proadrenomedullin plasma concentrations differed considerably among the 4 groups (Table <ref type="table" target="#tab_1">1</ref> and eTable 3 in Supplement 2).</s><s>We found a statistically significant interaction between the 2 study interventions regarding the primary end point (P = .03)</s><s>(Table <ref type="table" target="#tab_2">2</ref>, eTable 4 in Supplement 2, and Figure <ref type="figure" target="#fig_1">2C</ref>).</s><s>Because there was no indication that selenium influenced the plasma procalcitonin levels or that procalcitonin guidance influenced the plasma selenium levels (eFigure 1 and eFigure 2 in Supplement 2), we decided to accept the observed statistical interaction as a chance finding and proceed with the factorial analysis as originally planned.</s><s>However, we also report the data in consideration of the significant interaction.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sodium Selenite Therapy</head><p><s>Study treatment with sodium selenite led to a significant increase of selenium plasma concentrations into the upper reference range compared with the placebo arm (eFigure 1 in Supplement 2).</s><s>Good adherence to the study protocol was observed (eTable 5 in Supplement 2).</s><s>Patients received the study medication within 15.8 hours (interquartile range, 10.2-20.5 hours) after onset of sepsis-induced organ failure.</s><s>Concomitant medications possibly interacting with sodium selenite treatment did not differ significantly between the groups (eTable 6 in Supplement 2).</s></p><p><s>Of 538 patients, there was no statistically significant difference in the 28-day mortality between the sodium selenite group (152 patients [28.3%]) and the placebo group (137 [25.5%]) (P = .30)</s><s>(Table <ref type="table" target="#tab_2">2</ref>) nor did the survival curves differ significantly between the 2 groups (Figure <ref type="figure" target="#fig_1">2A</ref>).</s><s>There were no significant differences in 28-day mortality in any of our a priori-specified subgroup analyses in the intention-to-treat analysis (eFigure 3A in Supplement 2).</s><s>Secondary outcomes are reported in Table <ref type="table" target="#tab_3">3</ref>. Patients in the sodium selenite group had fewer renal replacement-free days (by 1 day) than the placebo group; hospital length of stay was significantly shorter by 3 days in the sodium selenite group.</s><s>Frequency of adverse and serious adverse events did not differ markedly between the placebo and the sodium selenite group (eTable 7 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Procalcitonin-Guided Therapy</head><p><s>The procalcitonin time course was known in 91.8% of the patients in the procalcitonin guidance group.</s><s>In 21.0% of the patients in the procalcitonin guidance group, at least 1 protocol deviation was detected (eTable 6 in Supplement 2).</s><s>The most frequent deviations were additional procalcitonin measurements not scheduled by the algorithm.</s><s>Adherence to the recommendation of the algorithm dropped to 40.9%  commencing by day 7 (eTable 8 in Supplement 2).</s><s>The treating physicians justified nonadherence to the algorithm by the presence of fever, microbiologic findings, and the course of the white blood cell count.</s><s>The recommendations to stop antimicrobial therapy were overruled by the treating physicians in 50.4% of the cases.</s><s>Procalcitonin plasma lev-els were equally elevated in both groups and decreased in both groups independent of the type of intervention (eFigure 2 in Supplement 2).</s><s>There was no statistically significant difference in 28-day mortality between the procalcitonin guidance (140 of 547 patients [25.6%]) and no procalcitonin guidance group (149 of 529 patients [28.2%];</s><s>P = .34)</s><s>(Table <ref type="table" target="#tab_2">2</ref>), nor did the survival curves differ between the 2 groups (Figure <ref type="figure" target="#fig_1">2B</ref>).</s><s>No significant differences in the primary outcome were observed in any of the a priori subgroup analyses in the intention-to-treat analysis (eFigure 3B in Supplement 2).</s><s>Secondary outcomes reported in Table <ref type="table" target="#tab_3">3</ref> did not differ significantly between the 2 groups.</s><s>The frequency of procedures for infection source control or diagnosis of the source of sepsis remained unaffected by the procalcitonin algorithm.</s><s>Antibiotic exposure per 1000 ICU days was reduced by 4.5% from 862 days in the conventional group to 823 days in the procalcitonin guidance group (P = .02).</s><s>Procalcitonin guidance was associated with an increase in antimicrobial-free days in the ICU (Figure <ref type="figure" target="#fig_1">2D</ref>) (P = .03),</s><s>but median antimicrobial-free days in the ICU were zero in both groups (Table <ref type="table" target="#tab_3">3</ref>).</s><s>Procalcitonin guidance was not associated with a reduction of costs of antimicrobial therapy (Table <ref type="table" target="#tab_3">3</ref>).</s><s>Clinical and microbiologic cure of infection were not different between the groups, and procalcitonin guidance did not affect the occurrence multiresistant pathogens (eTables 9 and 10 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of Procalcitonin-Selenium Interaction on Primary Outcome</head><p><s>There was a significantly higher 28-day mortality in patients assigned to no procalcitonin guidance in the sodium selenite group compared with the placebo group (33.3% vs 22.9%; P = .008)</s><s>(Table <ref type="table" target="#tab_2">2</ref>).</s><s>Some of the baseline variables were unequally distributed, with a higher rate of renal replacement therapy at enrollment, more emergency surgery, and higher midregional proadrenomedullin concentrations in the sodium selenite group (Table <ref type="table" target="#tab_1">1</ref>).</s><s>The difference in the primary outcome between the placebo and sodium selenite groups remained statistically significant after adjustment for these baseline differences (Table <ref type="table" target="#tab_2">2</ref>).</s><s>There was no significant difference in the primary outcome regarding procalcitonin guidance (27.9%) vs no procalcitonin guidance (22.9%) (P = .18),</s><s>but there were significantly fewer antimicrobial exposure days per 1000 ICU days in the procalcitonin guidance group (832 vs 878 days; P = .05)</s><s>(eTable 11 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>To our knowledge, this is the first multicenter randomized clinical trial with an adequate sample size to evaluate the clinical efficacy of sodium selenite therapy and the efficacy of a procalcitonin-guided algorithm in patients with severe sepsis.</s><s>Neither treatment with intravenous administration of high-dose sodium selenite nor the procalcitonin algorithm implemented in our study to guide diagnostic and antimicrobial measures was associated with improved 28-day mortality in patients with severe sepsis.</s><s>Procalcitonin guidance did not affect resource allocation assessed by frequency of diagnostic or therapeutic procedures but did result in a reduction of antimicrobial exposure per 1000 patient-days by 4.5%.</s><s>We observed a statistically significant interaction between sodium selenite and procalcitonin and, although this interaction may be spurious, if real, we found a significant increase in mortality with selenium therapy.</s></p><p><s>In previous studies, the ineffectiveness of selenium administration was believed to be attributed to underdosing, <ref type="bibr" target="#b7">6,</ref><ref type="bibr" target="#b28">21</ref> lack of an initial loading dose, short-term treatment, <ref type="bibr" target="#b29">22</ref> or inclusion of patients with normal selenium plasma concentrations at baseline. <ref type="bibr" target="#b9">8</ref></s><s>Instead, we used a dosage regimen that was associated with improved survival in another randomized trial. <ref type="bibr" target="#b8">7</ref></s><s>In contrast to a recent study 8 conducted in North America, baseline plasma selenium levels were subnormal in our study.</s><s>Plasma selenium concentrations were within the reference range on the day of study inclusion in the sodium selenite group but remained low in the placebo group.</s><s>Thus, a separation of selenium concentrations was achieved early between the 2 groups.</s><s>In a recent post hoc analysis 23 of a large a Primary end point was 28-day mortality.</s><s>The significance level was adjusted by the α spending method <ref type="bibr" target="#b26">19</ref> resulting in a significance level of .044.</s><s>b Sodium selenite vs placebo in only the no procalcitonin guidance group.</s></p><p><s>Analysis was conducted under consideration of interaction (unadjusted and adjusted): variables for multivariate regression were defined a priori in the analysis plan.</s><s>Midregional proadrenomedullin and lactate were also selected because they showed a clinically relevant imbalance at baseline.</s><s>c Sodium selenite vs placebo regardless of allocation to procalcitonin guidance or no guidance.</s></p><p><s>d Procalcitonin guidance vs no guidance only in the placebo group.</s><s>Midregional proadrenomedullin and lactate were also selected because they showed a clinically relevant imbalance at baseline.</s><s>Analysis was conducted under consideration of interaction (unadjusted and adjusted).</s><s>e Procalcitonin guidance vs no procalcitonin guidance regardless of the allocation to the sodium selenite or placebo group.</s></p><p><s>multicenter trial, patients with renal dysfunction were reported to have a greater risk of harm when treated with antioxidants.</s><s>However, we could not confirm this finding in an unplanned subgroup analysis of our study (eTable 12 in Supplement 2).</s></p><p><s>Procalcitonin guidance had no effect on the frequency of diagnostic procedures, interventions for source control, and readjustment of empirical antimicrobial therapy.</s><s>This lack of effect explains why the outcomes of the study were not affected by application of this procalcitonin algorithm.</s><s>Thus, our data suggest that the procalcitonin algorithm provided no added value to the clinical judgment for initiating antimicrobial measures.</s><s>Our findings are in line with those of another randomized trial <ref type="bibr" target="#b20">15</ref> in critically ill patients in which procalcitonin guidance of diagnostic and therapeutic measures did not improve survival but increased the duration of mechanical ventilation, prolonged antimicrobial therapy, and resulted in more microbiologic sampling.</s><s>In a recent study <ref type="bibr" target="#b19">14</ref> on less-sick pa-tients, a procalcitonin algorithm designed for early discontinuation of antimicrobial therapy showed a lower mortality rate in the procalcitonin guidance group.</s><s>The authors speculated that knowledge of procalcitonin concentrations would lead to earlier and more adequate diagnosis and therapy.</s><s>However, we could not confirm that a procalcitonin algorithm would change antimicrobial measures.</s></p><p><s>The procalcitonin algorithm used by Jensen and coworkers 15 included additional diagnostic and therapeutic measures in all patients when procalcitonin concentrations determined on a daily basis did not drop by more than 10% or remained above 1 ng/mL.</s><s>Their procalcitonin algorithm obviously resulted in increased use of broad-spectrum antibiotics and potential harm.</s><s>Although the algorithm used in our study did not affect mortality, it resulted in a small reduction of antimicrobial exposure.</s><s>Studies <ref type="bibr" target="#b31">[24]</ref><ref type="bibr" target="#b32">[25]</ref><ref type="bibr" target="#b33">[26]</ref> in less-sick patient populations with mortality rates between 5% and 20% found reduced durations of antimicrobial therapy without jeopardizing sur- vival.</s><s>We did not observe such an effect in our study.</s><s>A reason for the lack of effect of procalcitonin guidance on the duration of antimicrobial therapy in our study may be that treating physicians overruled the algorithm in up to 50.4% of the decision situations.</s><s>Obviously, physicians refrained from discontinuing antimicrobials solely based on 1 biomarker in these high-risk patients, 87.0% of whom had septic shock.</s></p><p><s>Procalcitonin-based algorithms in less-sick patients have achieved higher adherence rates of 81% and 91%. <ref type="bibr" target="#b32">25,</ref><ref type="bibr" target="#b33">26</ref></s><s>In general, current data also support a shorter duration of antimicrobial therapy in critically ill patients. <ref type="bibr" target="#b35">27,</ref><ref type="bibr" target="#b36">28</ref></s><s>Such trials may have generally affected prescribing behavior since the duration of antimicrobial therapy in the present study was shorter than in a former trial by our study group. <ref type="bibr" target="#b37">29</ref></s><s>This change in prescription behavior may also have contributed to the lesser effectiveness of the procalcitonin algorithm.</s></p><p><s>The procalcitonin algorithm in our study differs from previously published algorithms.</s><s>Although a procalcitonin concentration of less than 0.1 ng/mL is a well-established cutoff for discontinuation of antimicrobial therapy, other studies <ref type="bibr" target="#b31">[24]</ref><ref type="bibr" target="#b32">[25]</ref><ref type="bibr" target="#b33">[26]</ref> used an 80% to 90% decrease from baseline or from procalcitonin peak concentration as a stopping rule.</s><s>The 50% rule in our study was based on the fact that such a decrease in procalcitonin concentration within 3 days is associated with improved survival. <ref type="bibr">30</ref></s><s>he strengths of this study include the randomized, placebo-controlled, and partially blinded design, the high rate of adherence to the study protocol regarding the sodium selenite intervention, and intention-to-treat analysis, all of which contribute to the internal validity of the trial.</s><s>Use of 33 sites supports generalizability of the findings to similar health care settings.</s><s>The time course of plasma selenium and procalcitonin concentrations were available in all patients and measured on a single device.</s><s>Our trial has limitations.</s><s>Observed 28-day mortality was lower than expected.</s><s>We cannot rule out that a trial with an even larger sample size might reveal a statistically significant difference in the primary outcome.</s><s>Unexpectedly, we found a statistically significant interaction between the 2 treatment factors that affects our interpretation of the primary outcome.</s><s>In the procalcitonin-guided group, sodium selenite administration had no treatment effect but seemed to harm patients not receiving procalcitonin-guided therapy even after adjustment for baseline differences.</s><s>We could not detect any interference between longitudinal profiles of plasma selenium and procalcitonin.</s><s>Thus, there was no clinically or biochemically plausible evidence that sodium selenite administration would alter procalcitonin concentrations in a way that could affect treatment decisions in the procalcitonin-guided group.</s><s>Furthermore, secondary outcomes regarding anti-infectious measures did not show relevant differences between the placebo and the sodium selenite group.</s><s>This finding led us to conclude that the statistically significant interaction occurred by chance and did not reflect a true biological interaction.</s><s>However, we cannot completely rule out a possible nonrandom interaction between the 2 interventions or that better adherence to the procalcitonin-guided algorithm would have improved the end points of the study.</s><s>We did not assess the oxidative status of the patients.</s><s>However, the effects of restoration of selenium concentrations on glutathione peroxidase activity are well described. <ref type="bibr" target="#b6">5</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>In conclusion, this trial demonstrates that neither high-dose intravenous administration of sodium selenite nor procalcitonin-guided antimicrobial therapy was associated with improved 28-day mortality in patients with severe sepsis.</s><s>Sodium selenite treatment remained ineffective although plasma selenium levels were normalized.</s><s>Procalcitonin guidance resulted in a reduction of antibiotic exposure by 4.5% but did not influence resource utilization.</s><s>These findings do not support administration of high-dose sodium selenite in critically ill patients.</s><s>The application of a procalcitonin-guided algorithm needs further evaluation.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>CONSORT Diagram</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2. Survival Curves</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Baseline Characteristics</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Sodium Selenite</cell><cell></cell><cell>Placebo</cell><cell></cell></row><row><cell></cell><cell></cell><cell>Procalcitonin</cell><cell>No Procalcitonin</cell><cell>Procalcitonin</cell><cell>No Procalcitonin</cell></row><row><cell></cell><cell>Total</cell><cell>Guidance</cell><cell>Guidance</cell><cell>Guidance</cell><cell>Guidance</cell></row><row><cell>Variable</cell><cell>(N = 1089)</cell><cell>(n = 273)</cell><cell>(n = 270)</cell><cell>(n = 279)</cell><cell>(n = 267)</cell></row><row><cell>Age, mean (SD), y</cell><cell>65.7 (13.7)</cell><cell>63.9 (14.9)</cell><cell>65.8 (14.3)</cell><cell>67.3 (12.4)</cell><cell>65.6 (12.7)</cell></row><row><cell>Male sex, No. (%)</cell><cell>691 (63.5)</cell><cell>175 (64.1)</cell><cell>170 (63.0)</cell><cell>177 (63.4)</cell><cell>169 (63.3)</cell></row><row><cell>BMI, mean (SD)</cell><cell>27.9 (6.9)</cell><cell>27.7 (7.8)</cell><cell>28.0 (7.5)</cell><cell>27.8 (5.7)</cell><cell>27.9 (6.7)</cell></row><row><cell>APACHE II score, mean (SD), points a</cell><cell>24.2 (7.6)</cell><cell>23.6 (7.9)</cell><cell>24.7 (7.6)</cell><cell>24.2 (7.2)</cell><cell>24.4 (7.7)</cell></row><row><cell>Septic shock, No. (%)</cell><cell>947 (87.0)</cell><cell>239 (87.5)</cell><cell>237 (87.8)</cell><cell>240 (86.0)</cell><cell>231 (86.5)</cell></row><row><cell>SOFA score, mean (SD), points b</cell><cell>10.0 (3.3)</cell><cell>9.8 (3.4)</cell><cell>10.3 (3.3)</cell><cell>10.0 (3.3)</cell><cell>9.9 (3.3)</cell></row><row><cell>Charlson comorbidity index, median (IQR)</cell><cell>2 (1-4)</cell><cell>2 (0-3)</cell><cell>2 (0-4)</cell><cell>2 (1-4)</cell><cell>2 (1-4)</cell></row><row><cell>Site of infection, No. (%) c</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Lung</cell><cell>494 (45.4)</cell><cell>135 (49.5)</cell><cell>119 (44.1)</cell><cell>126 (45.2)</cell><cell>114 (42.7)</cell></row><row><cell>Thoracic</cell><cell>44 (4.0)</cell><cell>13 (4.8)</cell><cell>7 (2.6)</cell><cell>14 (5.0)</cell><cell>10 (3.7)</cell></row><row><cell>Abdomen</cell><cell>418 (38.4)</cell><cell>101 (37.0)</cell><cell>113 (41.9)</cell><cell>97 (34.8)</cell><cell>107 (40.1)</cell></row><row><cell>Bones/soft tissue</cell><cell>80 (7.3)</cell><cell>21 (7.7)</cell><cell>15 (5.6)</cell><cell>21 (7.5)</cell><cell>23 (8.6)</cell></row><row><cell>Surgical wound</cell><cell>41 (3.8)</cell><cell>7 (2.6)</cell><cell>13 (4.8)</cell><cell>6 (2.2)</cell><cell>15 (5.6)</cell></row><row><cell>Urogenital</cell><cell>100 (9.2)</cell><cell>20 (7.3)</cell><cell>30 (11.1)</cell><cell>27 (9.7)</cell><cell>23 (8.6)</cell></row><row><cell>Primary bacteremia</cell><cell>32 (2.9)</cell><cell>12 (4.4)</cell><cell>4 (1.5)</cell><cell>9 (3.2)</cell><cell>7 (2.6)</cell></row><row><cell>Other d</cell><cell>66 (6.1)</cell><cell>23 (8.4)</cell><cell>16 (5.9)</cell><cell>16 (5.7)</cell><cell>11 (4.1)</cell></row><row><cell>Unknown</cell><cell>41 (3.8)</cell><cell>6 (2.2)</cell><cell>10 (3.7)</cell><cell>14 (5.0)</cell><cell>11 (4.1)</cell></row><row><cell>Recent surgical history, No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Elective</cell><cell>122 (11.2)</cell><cell>25 (9.2)</cell><cell>24 (8.9)</cell><cell>37 (13.3)</cell><cell>36 (13.5)</cell></row><row><cell>Emergency</cell><cell>494 (45.4)</cell><cell>135 (49.5)</cell><cell>128 (47.4)</cell><cell>128 (45.9)</cell><cell>103 (38.6)</cell></row><row><cell>None</cell><cell>473 (43.4)</cell><cell>113 (41.4)</cell><cell>118 (43.7)</cell><cell>114 (40.9)</cell><cell>128 (47.9)</cell></row><row><cell>Laboratory values, median (IQR)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>White blood cell count, /μL</cell><cell>15 800</cell><cell>15 300</cell><cell>16 000</cell><cell>15 400</cell><cell>16 100</cell></row><row><cell></cell><cell>(10 300-22 700)</cell><cell>(10 600-21 800)</cell><cell>(10 100-22 600)</cell><cell>(10 100-23 200)</cell><cell>(11000-22 800)</cell></row><row><cell>C-reactive protein, mg/L</cell><cell>188.0</cell><cell>208.5</cell><cell>180.4</cell><cell>206.0</cell><cell>182.0</cell></row><row><cell></cell><cell>(120.0-282.0)</cell><cell>(123.1-283.0)</cell><cell>(118.5-267.5)</cell><cell>(129.0-288.0)</cell><cell>(115.0-282.0)</cell></row><row><cell>Procalcitonin, ng/mL</cell><cell>7.37</cell><cell>6.43</cell><cell>8.15</cell><cell>7.18</cell><cell>7.30</cell></row><row><cell></cell><cell>(1.59-26.59)</cell><cell>(1.33-21.98)</cell><cell>(1.91-30.83)</cell><cell>(1.48-28.24)</cell><cell>(1.69-22.60)</cell></row><row><cell>Lactate, mmol/L</cell><cell>2.7</cell><cell>2.6</cell><cell>2.8</cell><cell>2.8</cell><cell>2.7</cell></row><row><cell></cell><cell>(1.6-4.7)</cell><cell>(1.6-4.2)</cell><cell>(1.7-5.4)</cell><cell>(1.7-4.7)</cell><cell>(1.7-4.7)</cell></row><row><cell>Selenium concentration, μg/L</cell><cell>39.4</cell><cell>40.9</cell><cell>38.6</cell><cell>38.6</cell><cell>39.4</cell></row><row><cell></cell><cell>(29.9-52.8)</cell><cell>(30.7-56.7)</cell><cell>(30.7-50.4)</cell><cell>(29.9-50.4)</cell><cell>(30.7-50.4)</cell></row><row><cell>Midregional proadrenomedullin, nmol/L</cell><cell>4.9</cell><cell>4.3</cell><cell>5.5</cell><cell>5.4</cell><cell>4.6</cell></row><row><cell></cell><cell>(2.6-8.8)</cell><cell>(2.2-7.9)</cell><cell>(2.8-9.0)</cell><cell>(3.0-9.4)</cell><cell>(2.7-8.2)</cell></row><row><cell>Sodium selenite therapy before inclusion,</cell><cell>124 (11.4)</cell><cell>30 (11.0)</cell><cell>30 (11.1)</cell><cell>32 (11.5)</cell><cell>32 (12.0)</cell></row><row><cell>No. (%) e</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total dose of sodium selenite before</cell><cell>1042</cell><cell>1000</cell><cell>1099</cell><cell>936</cell><cell>1119</cell></row><row><cell>inclusion, median (IQR), μg e</cell><cell>(500-1426)</cell><cell>(280-1151)</cell><cell>(300-1352)</cell><cell>(509-1654)</cell><cell>(814-1538)</cell></row><row><cell>Supportive therapy at inclusion, No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Required mechanical ventilation</cell><cell>794 (72.9)</cell><cell>200 (73.3)</cell><cell>200 (74.1)</cell><cell>213 (76.3)</cell><cell>181 (67.8)</cell></row><row><cell>Required renal replacement therapy</cell><cell>178 (16.4)</cell><cell>36 (13.2)</cell><cell>60 (22.2)</cell><cell>39 (14.0)</cell><cell>43 (16.1)</cell></row><row><cell cols="3">Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation;</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">BMI, body mass index (calculated as weight in kilograms divided by height in</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">meters squared); IQR, interquartile range; SOFA, Sequential Organ Failure</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Assessment.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">SI conversion factors: To convert C-reactive protein to nanomoles per liter,</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">multiply by 9.524; lactate to milligrams per deciliter, divide by 0.111; selenium to</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">micromoles per liter, multiply by 0.0127; and white blood cell count to ×10 9 /L,</cell><cell></cell><cell></cell><cell></cell></row><row><cell>multiply by 0.001.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a Missing subscores counted as 0.b Missing subscores imputed by values at day 0 or day 1. c Multiple responses per patient possible.</s><s>d Other infection sources included catheter, central nervous system, and cardiovascular.</s><s>e Up to 7 days before study inclusion.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Primary End Point a</s></p></div></figDesc><table><row><cell></cell><cell cols="2">No./Total No. (%) [95% CI]</cell><cell></cell><cell cols="2">P Value for Sodium Selenite vs Placebo</cell></row><row><cell>Variable</cell><cell>Placebo</cell><cell>Sodium Selenite</cell><cell>Total</cell><cell>Unadjusted</cell><cell>Adjusted</cell></row><row><cell>No procalcitonin guidance</cell><cell>60/262 (22.9)</cell><cell>89/267 (33.3)</cell><cell>149/529 (28.2)</cell><cell>.008 b</cell><cell>.03 b</cell></row><row><cell></cell><cell>[18.0-28.5]</cell><cell>[27.7-39.3]</cell><cell>[24.4-32.2]</cell><cell></cell><cell></cell></row><row><cell>Procalcitonin guidance</cell><cell>77/276 (27.9)</cell><cell>63/271 (23.2)</cell><cell>140/547 (25.6)</cell><cell>.21</cell><cell>.30</cell></row><row><cell></cell><cell>[22.7-33.6]</cell><cell>[18.4-28.7]</cell><cell>[22.0-29.5]</cell><cell></cell><cell></cell></row><row><cell>Total</cell><cell>137/538 (25.5)</cell><cell>152/538 (28.3)</cell><cell>289/1076 (26.9)</cell><cell>.30 c</cell><cell></cell></row><row><cell></cell><cell>[21.8-29.4]</cell><cell>[24.5-32.3]</cell><cell>[24.2-29.6]</cell><cell></cell><cell></cell></row><row><cell>P value for procalcitonin guidance vs no</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>guidance</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted</cell><cell>.18 d</cell><cell>.009</cell><cell>.34 e</cell><cell></cell><cell></cell></row><row><cell>Adjusted</cell><cell>.44 d</cell><cell>.04</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Secondary End Points Mean SOFA score is the sum of daily SOFA scores during the observation period divided by the duration of the observation period.cDollars</s><s>were converted from euros using the exchange rate as ofMay 13, 2016(1.1325).</s><s>d Analyzed by the Kaplan-Meier method.</s></p></div></figDesc><table><row><cell cols="4">Association of Sodium Selenite and Procalcitonin-Guided Therapy With Mortality</cell><cell></cell><cell></cell><cell cols="2">Original Investigation Research</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>No Procalcitonin</cell><cell></cell></row><row><cell></cell><cell>Total</cell><cell>Sodium Selenite</cell><cell>Placebo</cell><cell></cell><cell>Procalcitonin Guidance</cell><cell>Guidance</cell><cell></cell></row><row><cell>Variable</cell><cell>(N = 1089)</cell><cell>(n = 543)</cell><cell>(n = 546)</cell><cell>P Value a</cell><cell>(n = 552)</cell><cell>(n = 537)</cell><cell>P Value a</cell></row><row><cell>90-d All-cause mortality,</cell><cell>1045</cell><cell>517</cell><cell>528</cell><cell></cell><cell>529</cell><cell>516</cell><cell></cell></row><row><cell>No.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patients not alive at 90 d,</cell><cell>399 (38.2)</cell><cell>198 (38.3)</cell><cell>201 (38.1)</cell><cell>.94</cell><cell>200 (37.8)</cell><cell>199 (38.6)</cell><cell>.80</cell></row><row><cell>No. (%) [95% CI]</cell><cell>[35.2-41.2]</cell><cell>[34.1-42.6]</cell><cell>[33.9-42.4]</cell><cell></cell><cell>[33.7-42.1]</cell><cell>[34.4-42.9]</cell><cell></cell></row><row><cell>SOFA score, mean (SD) b</cell><cell>7.95 (4.07)</cell><cell>8.01 (4.22)</cell><cell>7.89 (3.92)</cell><cell>.62</cell><cell>7.78 (3.98)</cell><cell>8.14 (4.17)</cell><cell>.17</cell></row><row><cell>SOFA subscores, median</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(IQR)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Cardiovascular</cell><cell>2.0 (1.2-3.2)</cell><cell>2.0 (1.1-3.2)</cell><cell>2.0 (1.2-3.1)</cell><cell>.83</cell><cell>2.0 (1.2-3.1)</cell><cell>2.0 (1.1-3.3)</cell><cell>.64</cell></row><row><cell>Respiratory</cell><cell>2.4 (2.0-2.9)</cell><cell>2.3 (2.0-2.9)</cell><cell>2.4 (1.9-2.8)</cell><cell>.90</cell><cell>2.3 (1.9-2.9)</cell><cell>2.4 (2.0-2.9)</cell><cell>.21</cell></row><row><cell>Coagulation</cell><cell>0.1 (0-1.0)</cell><cell>0.1 (0-1.0)</cell><cell>0.1 (0-0.9)</cell><cell>.95</cell><cell>0.1 (0-0.8)</cell><cell>0.1 (0-1.0)</cell><cell>.03</cell></row><row><cell>Renal</cell><cell>0.5 (0-2.0)</cell><cell>0.4 (0-2.0)</cell><cell>0.5 (0-2.0)</cell><cell>.63</cell><cell>0.5 (0-2.0)</cell><cell>0.5 (0-2.0)</cell><cell>.26</cell></row><row><cell>Hepatic</cell><cell>0 (0-0.6)</cell><cell>0 (0-0.6)</cell><cell>0 (0-0.7)</cell><cell>.85</cell><cell>0 (0-0.7)</cell><cell>0 (0-0.6)</cell><cell>.87</cell></row><row><cell>Central nervous system</cell><cell>0.6 (0-2.0)</cell><cell>0.7 (0-2.0)</cell><cell>0.5 (0-2.0)</cell><cell>.44</cell><cell>0.6 (0-2.0)</cell><cell>0.5 (0-1.9)</cell><cell>.56</cell></row><row><cell>Length of stay, median</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(IQR), d</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ICU</cell><cell>12 (6-23)</cell><cell>11 (5-22)</cell><cell>12 (6-24)</cell><cell>.08</cell><cell>12 (6-24)</cell><cell>11 (6-21)</cell><cell>.14</cell></row><row><cell>Hospital</cell><cell>28 (17-45)</cell><cell>26 (16-42)</cell><cell>29 (17-50)</cell><cell>.02</cell><cell>29 (18-46)</cell><cell>26 (16-44)</cell><cell>.10</cell></row><row><cell>Intervention-free days,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>median (IQR)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ventilator</cell><cell>2 (0-5)</cell><cell>2 (0-5)</cell><cell>2 (0-5)</cell><cell>.22</cell><cell>2 (0-5)</cell><cell>2 (0-5)</cell><cell>.26</cell></row><row><cell>RRT</cell><cell>7 (3-16)</cell><cell>7 (2-15)</cell><cell>8 (3-18)</cell><cell>.05</cell><cell>7 (3-17)</cell><cell>7 (2-16)</cell><cell>.34</cell></row><row><cell>Vasopressor</cell><cell>4 (1-10)</cell><cell>3 (1-9)</cell><cell>4 (1-10)</cell><cell>.10</cell><cell>4 (1-10)</cell><cell>4 (1-10)</cell><cell>.33</cell></row><row><cell>AT</cell><cell>0 (0-3)</cell><cell>0 (0-3)</cell><cell>0 (0-4)</cell><cell>.86</cell><cell>0 (0-4)</cell><cell>0 (0-3)</cell><cell>.03</cell></row><row><cell>Duration of AT in ICU for</cell><cell>7 (3-12)</cell><cell>7 (3-11)</cell><cell>7 (4-13)</cell><cell>.02</cell><cell>7 (3-12)</cell><cell>7 (3-12)</cell><cell>.93</cell></row><row><cell>first septic episode,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>median (IQR), d</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Cost of AT in ICU, median</cell><cell>118 (44-512)/</cell><cell>102 (43-414)/</cell><cell>137 (45-684)/</cell><cell>.08</cell><cell>118 (45-563)/</cell><cell>119 (44-492)/</cell><cell>.83</cell></row><row><cell>(IQR), $/€ c</cell><cell>104 (39-452)</cell><cell>90 (38-366)</cell><cell>121 (40-604)</cell><cell></cell><cell>104 (40-497)</cell><cell>105 (39-434)</cell><cell></cell></row><row><cell>AT exposure days per</cell><cell>842 (825-858)</cell><cell>827 (804-852)</cell><cell>855 (832-878)</cell><cell>.11</cell><cell>823 (800-846)</cell><cell>862 (838-886)</cell><cell>.02</cell></row><row><cell>1000 ICU days, median</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(IQR)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Time to change of AT,</cell><cell>7 (3-17)</cell><cell>7 (3-16)</cell><cell>7 (3-17)</cell><cell>.94</cell><cell>7 (3-16)</cell><cell>7 (3-21)</cell><cell>.96</cell></row><row><cell>median (range), d d</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Secondary infections, %</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(95% CI) d</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Day 14</cell><cell cols="3">47.2 (43.1-51.4) 44.7 (39.0-50.9) 49.3 (43.7-55.3)</cell><cell></cell><cell>47.9 (42.3-53.8)</cell><cell>46.4 (40.5-52.6)</cell><cell></cell></row><row><cell>Day 21</cell><cell cols="3">59.0 (54.0-64.0) 58.8 (51.4-66.5) 59.2 (52.7-65.8)</cell><cell>.68</cell><cell>57.9 (51.5-64.6)</cell><cell>60.3 (52.8-68.0)</cell><cell>.76</cell></row><row><cell>Patients with source</cell><cell>447 (41.0)</cell><cell>208 (38.3)</cell><cell>239 (43.8)</cell><cell>.07</cell><cell>239 (43.3)</cell><cell>208 (38.7)</cell><cell>.13</cell></row><row><cell>control, No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No. of procedures per</cell><cell>2 (1-3)</cell><cell>2 (1-3)</cell><cell>2 (1-3)</cell><cell>.90</cell><cell>2 (1-3)</cell><cell>2 (1-3)</cell><cell>.99</cell></row><row><cell>patient, median (IQR) e</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patients with procedures</cell><cell>975 (89.5)</cell><cell>485 (89.32)</cell><cell>490 (89.74)</cell><cell>.84</cell><cell>496 (89.9)</cell><cell>479 (89.2)</cell><cell>.72</cell></row><row><cell>to diagnose infection,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No. of procedures per</cell><cell>9 (4-19)</cell><cell>8 (3-18)</cell><cell>9 (4-20)</cell><cell>.07</cell><cell>9 (4-19)</cell><cell>9 (4-18)</cell><cell>.52</cell></row><row><cell>patient e</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">Abbreviations: AT, antimicrobial therapy; ICU, intensive care unit;</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">IQR, interquartile range; RRT, renal replacement therapy; SOFA, Sequential</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Organ Failure Assessment.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">a Values calculated by exact t test, χ 2 test, Wilcoxon rank sum test or log-rank</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>test, as appropriate.</cell><cell></cell><cell></cell><cell cols="4">e Determined if patients had undergone procedures.</cell><cell></cell></row></table><note><p><s>b jamainternalmedicine.com (Reprinted) JAMA Internal Medicine September 2016 Volume 176, Number 9</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JAMA Internal Medicine September 2016 Volume 176, Number 9 (Reprinted) jamainternalmedicine.com Copyright 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 05/17/2022</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 05/17/2022</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Author Contributions: Dr Bloos and Ms Trips contributed equally to this work.</s><s>Dr Reinhart had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</s><s>Funding/Support: The study infrastructure was partially funded by grant 01 KI 0106 from the German Federal Ministry of Education and Research.</s><s>Biosyn (Germany) and ThermoFischer (Germany) provided study medication and financial support via unrestricted grants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role of the Funder/Sponsor:</head><p><s>The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical Data Collection and</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><surname>Pezechk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Balkema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Christmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Meier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ledinko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Matheis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kreuzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Keemether</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rehfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joswig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Petrasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sonnemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Maahs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laetsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Savelsberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grunow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Klaproth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lohmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pizevska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Töpfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spielvogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Weissbrod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kernchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ottersbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Guderian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gerber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Christel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Füllekrug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Molz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Scharf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gramzow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ibs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sothmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Radtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bentner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Braune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bloos</surname></persName>
		</author>
		<title level="m">Study Nurses and Students Contributing to the Trial</title>
				<imprint/>
	</monogr>
	<note>Redlich, A. Haucke, A. Noack, D. Fergen, N</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Schulz-Ruhtenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>D'aria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dathe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schlegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Reinhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göring-Sparn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kircher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Büschges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wempe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Diers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alfke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Trabitzsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Goeschl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sudhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hoppstock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Feyahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gebhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mühlhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pense</surname></persName>
		</author>
		<author>
			<persName><surname>Buderus</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Oxidative stress and mitochondrial dysfunction in sepsis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Galley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="64" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sakr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bloos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="775" to="784" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Serum selenium and zinc levels in critically ill surgical patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Crit Care</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="317" to="e322" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e8</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation</title>
		<author>
			<persName><forename type="first">W</forename><surname>Manzanares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Biestro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Galusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Facchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hardy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1120" to="1127" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">High-dose selenium substitution in sepsis: a prospective randomized clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Valenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Brodská</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Drabek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hendl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kazda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="808" to="815" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">W</forename><surname>Alhazzani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jacobi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sindi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1555" to="1564" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock</title>
		<author>
			<persName><forename type="first">Mwa</forename><surname>Angstwurm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Engelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zimmermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="118" to="126" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Heyland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muscedere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Wischmeyer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients</title>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page">1853</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>published correction appears in</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1489" to="1497" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Dellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rhodes</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012</title>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="580" to="637" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prkno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schlattmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="426" to="435" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Procalcitonin as a marker of the systemic inflammatory response to infection</title>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Karzai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meisner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1193" to="1200" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Harbarth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Holeckova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Froidevaux</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis</title>
		<author>
			<persName><forename type="first">Geneva Sepsis</forename><surname>Network</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="396" to="402" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">New approaches to sepsis: molecular diagnostics and biomarkers</title>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Riedemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hartog</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="609" to="634" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Van Oers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beishuizen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="53" to="53" />
			<date type="published" when="2016-02">2016. February</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">U</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lundgren</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">PASS) Group. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial</title>
		<author>
			<persName><forename type="first">Survival</forename><surname>Procalcitonin</surname></persName>
		</author>
		<author>
			<persName><surname>Study</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2048" to="2058" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marx</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial</title>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="2390" to="2399" />
			<date type="published" when="2012">2012</date>
		</imprint>
		<respStmt>
			<orgName>German Study Group Competence Network Sepsis (SepNet</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Pocock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Trials</title>
		<imprint>
			<date type="published" when="2013">2013</date>
			<publisher>John Wiley &amp; Sons</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Diagnosis and causal treatment of sepsis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reinhart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Internist (Berl)</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="810" to="816" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>in German</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Discrete sequential boundaries for clinical trials</title>
		<author>
			<persName><forename type="first">Kkg</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Demets</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrika</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="659" to="663" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A multiple testing procedure for clinical trials</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Fleming</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="549" to="556" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Heyland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dhaliwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Suchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Berger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="327" to="337" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">T-S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y-C</forename><surname>Shyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-Y</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e54431</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Canadian Critical Care Trials Group. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Heyland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Elke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JPEN J Parenter Enteral Nutr</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="401" to="409" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Use of procalcitonin to reduce patients&apos; exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bouadma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-E</forename><surname>Luyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tubach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="issue">9713</biblScope>
			<biblScope unit="page" from="463" to="474" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PRORATA trial group</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial</title>
		<author>
			<persName><forename type="first">V</forename><surname>Nobre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harbarth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-D</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rohner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pugin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="498" to="505" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Schuetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Christ-Crain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thomann</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial</title>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1059" to="1066" />
			<date type="published" when="2009">2009</date>
		</imprint>
		<respStmt>
			<orgName>ProHOSP Study Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Chastre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-Y</forename><surname>Fagon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="2588" to="2598" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Trial of short-course antimicrobial therapy for intraabdominal infection</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Sawyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Claridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Nathens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="1996" to="2005" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Intensive insulin therapy and pentastarch resuscitation in severe sepsis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Brunkhorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bloos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="125" to="139" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>German Competence Network Sepsis (SepNet)</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study</title>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">R205</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
		<respStmt>
			<orgName>Finnsepsis Study Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
